| UNIVERSITAT ULM Patent applications |
| Patent application number | Title | Published |
|---|
| 20120045009 | TRANSMISSION DEVICE FOR GENERATING AN ANALOG MODULATED PULSE TRAIN AND FOR TRANSMITTING THE SAME AND A RECEIVING DEVICE FOR RECEIVING A RESPECTIVE SIGNAL - The present invention relates to a transmitting device and to a receiving device. In particular, it relates to a transmitting device for producing an analogue modulated pulse train and for emitting the same, comprising a pulse generator ( | 02-23-2012 |
| 20120032750 | ANGLED JUNCTION BETWEEN A MICROSTRIP LINE AND A RECTANGULAR WAVEGUIDE - The present invention relates, in the field of high frequency technology, to a transition element for transferring an electromagnetic wave in a strip transmission line into a waveguide. A waveguide with a first opening is thereby applied on a substrate, on which in addition strip transmission line and strip transmission line stub are situated, and contacted and/or coupled to a strip transmission line or to a strip transmission line and a strip transmission line stub. In the first opening, an electrical field then forms a wave in the strip transmission line. | 02-09-2012 |
| 20110104127 | mRNA-TRANSFECTION OF ADULT PROGENITOR CELLS FOR SPECIFIC TISSUE REGENERATION - The present invention relates to progenitor cells, medicaments containing progenitor cells and also uses thereof for specific tissue regeneration. Such processes are required in all medical sectors, in particular in the treatment of cardiovascular, haematological, nephrological, neurological, dermatological, gastroenterological or orthopaedic disorders. The progenitor cells are characterized in that they are transfected with mRNA which codes for a protein which promotes colonization of the progenitor cells in a target tissue and/or the differentiation of the progenitor cells in target cells or target tissue cells. | 05-05-2011 |
| 20110005942 | III-V NITRIDE SEMICONDUCTOR DEVICE COMPRISING A DIAMOND LAYER - The invention relates to a semiconductor device, in particular to a chemical field effect transistor (ChemFET), a high-electron mobility transistor (HEMT) and an ion-sensitive field effect transistor (ISFET), as well as a method for manufacturing the same. The semiconductor device comprises a structure, the structure comprises a substrate, a first layer comprising GaN and a second layer comprising InAlN, wherein the first and the second layer are arranged parallely to each other on the substrate, and wherein the structure comprises a third layer comprising diamond. | 01-13-2011 |
| 20100324176 | BIODEGRADABLE COMPOSITE SYSTEM AND THE USE THEREOF - The invention relates to a composite system comprising at least one biodegradable blend, containing at least one biodegradable block copolyester urethane (PEU) and also at least one polyhydroxyalkanoate (PHA), possibly a filler comprising a polysaccharide and/or derivatives thereof and also possibly further biocompatible additives. Composite systems of this type are used for producing moulded articles, moulded parts or extrudates. Furthermore, the invention relates to possibilities for using the composite system. | 12-23-2010 |
| 20090217980 | Organic Photoactive Device - The invention relates to an organic photoactive device, especially an organic photovoltaic cell, with a contact and a countercontact as well as with an organic region that is electrically connected to the contact and the countercontact, wherein a photoactive region with a photoactive bulk heterojunction or a flat heterojunction between an electron-conducting organic material and a hole-conducting organic material is formed in the organic region and wherein the hole-conducting organic material and/or the electron-conducting organic material is formed from oligomers according to any one of the following types: conjugated acceptor-donor-acceptor oligomer (A-D-A′ oligomer) with an acceptor unit (A) and a further acceptor unit (A′) that are each connected to a donor unit (D), and conjugated donor-acceptor-donor oligomer (D-A-D′ oligomer) with a donor unit (D) and a further donor unit (D′) that are each connected to an acceptor unit (A). | 09-03-2009 |
| 20090197953 | Pharmaceutical composition for the specific treatment of acute myeloid leukemia - The present invention provides the use of all-trans retinoic acid for the production of a pharmaceutical composition for the treatment of acute myeloid leukemia, which use is characterized in that the patients are selected from the group of non-M3 acute myeloid leukemia patients according to a physiologic concentration, e.g. a level of MN1 below a certain critical level analysed in total blood cells, preferably analysed in bone marrow cells. The critical level of MN1 can be determined according to known methods, e.g. by specific determination of the presence of MN1, e.g. using specific anti-MN1 antibody, e.g. in an ELISA or in another immuno specific assay. Preferably, the level of MN1 is determined at its transcription level, e.g. as the concentration of mRNA encoding MN1. | 08-06-2009 |
